Loading chat...
LA HB403
Bill
Status
Passed
6/6/2023
Primary Sponsor
Chad Brown
Click for details
AI Summary
Legislative Description
Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols
INSURANCE
Last Action
Effective date: 08/01/2023.
6/6/2023
Committee Referrals
Insurance5/16/2023
Insurance3/30/2023
Full Bill Text
No bill text available